Skip to main content

CASI Pharmaceuticals, Inc (DE)

CASIDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000895051

CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.

Superinvestors holding CASI, Q4 2022

See all superinvestors

No superinvestor reported holding CASI in Q4 2022.